
According to a research report titled "Microbiological Testing of Water Market by Pathogen type (Legionella, Coliform, Salmonella, Clostridium, Vibrio), Type (Instruments, Reagents & Test Kits), Water Type (Drinking & Bottle, Industrial water), Industry and Region - Global Forecast to 2027," published by MarketsandMarkets, the microbiological testing of water market was estimated to be worth USD 1.6 billion in 2022. The market is projected to grow at a compound annual growth rate (CAGR) of 7.4% to reach USD 2.3 billion by 2027.
(To get Quick Response use Corporate E-Mail-Id)
Key Highlights:
- Reagents and Test Kits Lead Growth: The segment of reagents and test kits is expected to achieve the highest CAGR in the microbiological testing of water market. Advancements in testing methods allowing for the analysis of larger sample sizes and reduced testing times contribute to this growth.
- Pharmaceutical Sector Dominance: The pharmaceutical industry is projected to dominate the microbiological testing of water market, holding the largest market share during the forecast period. Microbiological water quality monitoring is crucial for drug development, ensuring pathogen-free water for pharmaceutical products and compliance with regulatory requirements and Good Manufacturing Practices (GMP).
- Asia Pacific Emerges as a Key Market: The Asia-Pacific region is poised to achieve the highest CAGR in the microbiological testing of water market. Increasing awareness of microbiological water contaminants and their impact on health, coupled with the growing demand for packaged drinking water, particularly in China, is driving market expansion in the region.
Key Market Players:
Leading companies in the microbiological testing of water market include 3M (US), Thermo Fisher Scientific Inc. (US), Danaher Corporation (US), Döhler Group (Germany), Agilent Technologies, Inc. (US), Shimadzu Corporation (Japan), Merck (Germany), PerkinElmer, Inc. (US), Bio-Rad Laboratories, Inc. (US), IDEXX Laboratories, Inc. (US), Avantor Inc. (US), Hardy Diagnostics (US), LaMotte Company (US), Accepta Ltd (UK), and General Laboratory Products (US). These players are actively expanding production facilities, launching new products, investing in research and development, and pursuing strategic acquisitions to strengthen their market presence and supply chain.